Cohen & Steers (NYSE: CNS) president awarded 924 dividend stock units
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Cohen & Steers, Inc. President and CIO Jon Cheigh reported an acquisition of 924 shares of common stock on a grant or award basis. These represent dividend equivalent restricted stock units tied to the issuer's first quarter 2026 dividend on prior unvested awards from January 2023, 2024, 2025 and 2026.
After this compensation-related grant, Cheigh holds 93,470 shares directly. An additional 77,170 shares are held indirectly by the Jon Young Cheigh 2024 Revocable Trust, where he and an immediate family member serve as trustees, reflecting previously reported shares now held in the trust.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Cheigh Jon
Role
President and CIO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 924 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 93,470 shares (Direct);
Common Stock — 77,170 shares (Indirect, By the Jon Young Cheigh 2024 Revocable Trust)
Footnotes (1)
- Shares held by the Jon Young Cheigh 2024 Revocable Trust, a revocable trust, of which Mr. Cheigh and an immediate family member serve as trustees. These shares were previously reported as directly owned by Mr. Cheigh and have been transferred to the trust. Such transfer was exempt from reporting under Rule 16a-13. Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's first quarter 2026 dividend and accrued to the reporting person on unvested restricted stock units granted in January 2023, January 2024, January 2025 and January 2026.
FAQ
What did Cohen & Steers (CNS) President Jon Cheigh report in this Form 4?
He reported receiving 924 shares of common stock as a grant. These are dividend equivalent restricted stock units linked to the company’s first quarter 2026 dividend on earlier unvested awards from January 2023, 2024, 2025 and 2026.
Did the Form 4 for CNS disclose any sales or dispositions by Jon Cheigh?
The Form 4 does not report any sales or dispositions. It shows one acquisition of 924 shares as a grant and a separate holding entry for 77,170 shares held indirectly through the Jon Young Cheigh 2024 Revocable Trust.